dr. bardia on dual targeting of the her2 receptor
Published 10 years ago • 151 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:27
dr bardia on current approaches to her2 breast cancer management
-
2:03
dr. bardia discusses recent advancements in the field of breast cancer
-
4:01
dual her2 blockade in early breast cancer
-
1:33
dr. bardia describes the snapshot assay for breast cancer
-
2:48
targeting her2 outside of breast cancer
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
28:42
my mom's story - metastatic breast cancer in the lungs
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
51:57
breaking news: updates from the 2024 asco annual meeting
-
1:38
dr. bardia on the clinical utility of liquid biopsies in breast cancer
-
1:12
dr. aditya bardia on rad1901 in er-positive metastatic breast cancer
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
1:28
dr. verma on targeting her2 in patients with early-stage disease
-
1:41
new dual targeting approach for combating hormone receptor positive breast cancer
-
4:33
the her pathway and cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
0:41
dr. freedman discusses dual her2-targeted therapy in breast cancer